This inventor holds 4 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1976-1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JA (1976 - 1978)
- Tokyo, JP (1978)
Company Filing History:
Years Active: 1976-1978
Title: Masao Hoshiyama: Innovator in Pharmaceutical Chemistry
Introduction
Masao Hoshiyama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 4 patents to his name, Hoshiyama's work focuses on anti-diabetic and cardiotonic agents.
Latest Patents
Hoshiyama's latest patents include innovative benzylalcohol derivatives and processes for their preparation. One of his notable inventions is a compound that can be synthesized by reducing a specific precursor compound. This compound, along with its pharmaceutically acceptable acid addition salt, has shown potential as an anti-diabetic agent. Another significant patent involves a compound that is prepared through catalytic hydrogenation, which is useful as a cardiotonic agent. The versatility of these compounds highlights Hoshiyama's expertise in creating effective pharmaceutical solutions.
Career Highlights
Masao Hoshiyama is currently associated with Tanabe Seiyaku Company, Limited, where he continues to advance his research in pharmaceutical innovations. His work has not only contributed to the scientific community but has also paved the way for new treatments in the medical field.
Collaborations
Hoshiyama has collaborated with notable colleagues, including Muneyoshi Ikezaki and Nobuo Ito. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Masao Hoshiyama's contributions to pharmaceutical chemistry are noteworthy, with a focus on developing innovative compounds for medical use. His patents reflect a commitment to advancing healthcare through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile